
|Videos|February 25, 2015
The Challenge of Getting Specialty Drugs from Manufacturer to Patient
Michael R. Hess, attorney with Bass Berry & Sims and outside general counsel to many of the largest independent specialty pharmacy companies, discusses how to overcome the hurdles that hinder patient access to specialty medications.
Advertisement
Michael R. Hess, attorney with Bass Berry & Sims and outside general counsel to many of the largest independent specialty pharmacy companies, discusses how to overcome the hurdles that hinder patient access to specialty medications.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Clinical Manifestations and Prognostic Impact of Anemia in Myelofibrosis
2
Understanding Myelofibrosis and the Central Role of JAK Pathway Dysregulation
3
Trump Announces Pricing Deals With 9 Drugmakers, Expanding Most-Favored-Nation Drug Pricing Strategy
4
Pharmacists’ Expanding Role in Optimizing Oral Endocrine and Targeted Breast Cancer Therapies
5




































































































































































































